{
    "2019-02-15": [
        [
            {
                "time": "2019-02-15",
                "original_text": "Johnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives'",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Apple Watch",
                        "collaboration",
                        "save lives"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "Johnson & Johnson International Fin Svc Co -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson",
                "features": {
                    "keywords": [
                        "Moody's",
                        "ratings",
                        "review",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings",
                "features": {
                    "keywords": [
                        "biotech",
                        "conferences",
                        "clinical trials",
                        "earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "This Is One Company That Could Break Up Bristol-Celgene Deal",
                "features": {
                    "keywords": [
                        "Bristol-Celgene",
                        "deal",
                        "break up"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "Here's The Dark Horse Contender That Could Break Up Bristol-Celgene",
                "features": {
                    "keywords": [
                        "Dark Horse",
                        "Bristol-Celgene",
                        "contender",
                        "break up"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "Health Care Sector Update for 02/15/2019: AKAO, ORPN, CGC, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "AKAO",
                        "ORPN",
                        "CGC",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}